Atlas Trials

Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL

Clinical trial NCT06393985 · RECRUITING

Trial details

NCT number
NCT06393985
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic Leukemia
Start date
2024-04-25
Primary completion
2026-04-25
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.